Skip to main content
Alpa Laboratories Limited logo

Alpa Laboratories Limited — Investor Relations & Filings

Ticker · ALPA ISIN · INE385I01010 LEI · 335800O2RIWENG8KPR59 BSE.NS Manufacturing
Filings indexed 321 across all filing types
Latest filing 2024-08-13 Regulatory Filings
Country IN India
Listing BSE.NS ALPA

About Alpa Laboratories Limited

https://alpalabs.in/

Alpa Laboratories Limited specializes in the development and manufacture of a broad range of pharmaceutical formulations for human and veterinary applications. The company's core capabilities include the production of small volume parenterals, such as liquid and dry powder injections, alongside solid orals like tablets and capsules. Its portfolio further extends to topical preparations including ointments, creams, gels, and ophthalmic/otic drops. Utilizing WHO-GMP certified manufacturing units, the organization provides extensive contract manufacturing and research services to prominent global healthcare brands. The company serves diverse therapeutic segments, including anti-infectives, analgesics, and nutritional supplements, maintaining a robust presence in both domestic and international markets through a commitment to stringent quality standards and technical excellence.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2024-08-13 English
Outcome of Board Meeting
Regulatory Filings
2024-08-13 English
Board Meeting — ALPA LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for…
Regulatory Filings
2024-08-03 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about an upcoming Board Meeting scheduled to consider the unaudited financial results for the quarter ended June 30, 2024, and to approve the notice of the 36th Annual General Meeting. It is an intimation or announcement of a future event rather than the actual financial results or reports themselves. The document length is only 1524 characters, which is quite short and consistent with a regulatory announcement. It does not contain any financial data or detailed report content. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-03 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (73 characters) and contains no substantive content, only a placeholder indicating an omitted picture. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2024-07-01 English
Financial Result Updates
Regulatory Filings
2024-05-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.